APTENSIO XR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Rhodes Pharmaceuticals L.p.. The primary component is Methylphenidate Hydrochloride.
Product ID | 42858-407_9468380f-2590-4c7a-9451-81776fa2cfaf |
NDC | 42858-407 |
Product Type | Human Prescription Drug |
Proprietary Name | APTENSIO XR |
Generic Name | (methylphenidate Hydrochloride) |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2015-04-17 |
Marketing Category | NDA / NDA |
Application Number | NDA205831 |
Labeler Name | Rhodes Pharmaceuticals L.P. |
Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
Active Ingredient Strength | 60 mg/1 |
Pharm Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2015-04-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205831 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-04-17 |
Ingredient | Strength |
---|---|
METHYLPHENIDATE HYDROCHLORIDE | 60 mg/1 |
SPL SET ID: | 5adedc01-ebf0-11e3-ac10-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
42858-401 | APTENSIO XR | (methylphenidate hydrochloride) |
42858-402 | APTENSIO XR | (methylphenidate hydrochloride) |
42858-403 | APTENSIO XR | (methylphenidate hydrochloride) |
42858-404 | APTENSIO XR | (methylphenidate hydrochloride) |
42858-405 | APTENSIO XR | (methylphenidate hydrochloride) |
42858-406 | APTENSIO XR | (methylphenidate hydrochloride) |
42858-407 | APTENSIO XR | (methylphenidate hydrochloride) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
APTENSIO XR 85838161 4822493 Live/Registered |
Rhodes Pharmaceuticals L.P. 2013-02-01 |